|
|
||||||||||||||||
As evidence about the importance of the private sector in healthcare delivery accumulates, emphasis is being placed on better understanding the opportunities and risks it creates. Private providers are often key sources of treatment for diseases of public health importance, such as malaria, sexually transmitted infections (STIs) and tuberculosis (TB). They are also an important source of care for poor people, who may use private providers nearly as much as better-off groups. But there are concerns about their quality and affordability. What do we mean by the “private sector”? The term “private sector” covers an enormous range of provider types. They include those who operate on a for-profit basis, and non-profit organisations. They range from highly qualified specialists through to “less-than-fully qualified” practitioners and untrained shopkeepers; and from complex organisations such as inpatient facilities or provider networks, to very simple organisations such as solo-practitioners or itinerant drug pedlars. The types of care provided also vary, from a complete service involving sophisticated diagnostics and treatment through to the sale of simple public health products such as drugs, mosquito nets or condoms. Often the boundary between public and private is blurred – individual practitioners may work in public and private practice at the same time (known as 'dual practice' - see Steve Jan); public hospitals may create “private wards” within their institutions; and commodities such as drugs and vaccines may leak from public sector fac Source(s): id21 Research Highlight: 26 March 2003
Further Information: Contact the contributor: kara.hanson@lshtm.ac.uk London School of Hygiene and Tropical Medicine, UK Other related links:
|
|
|||||||||||||||
|
|
|
|
|
|
||||||||||||